Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩73.59T | 57.1x | 1.34 | ₩1,019,000 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩34.13T | 67.6x | 59.95 | ₩163,100 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩20.36T | 143.5x | 0.38 | ₩368,500 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.72T | 125x | -2.48 | ₩103,800 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.72T | 125x | -2.48 | ₩98,400 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩7.02T | 29x | 0.02 | ₩90,400 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩6.74T | -38x | 1.17 | ₩52,300 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.99T | 42.3x | 0.96 | ₩479,000 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.6% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.05T | 171x | 1.18 | ₩107,400 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
Classys Inc | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩3.86T | 1.68 | ₩58,500 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.7% Upside | Upgrade to Pro+ | ||
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.79T | 35.6x | -1.17 | ₩293,500 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.75T | -226.2x | 9.01 | ₩157,300 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.71T | -53.5x | 0.66 | ₩75,800 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.62T | -70x | 0.24 | ₩46,150 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.3% Downside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.39T | 28.4x | 0.46 | ₩327,000 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.5% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.38T | -292.8x | 16.56 | ₩152,100 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.22T | ₩38,950 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩2.36T | 45.5x | -0.81 | ₩37,050 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.14T | 80.1x | ₩49,300 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.94T | 43.1x | -0.71 | ₩160,600 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.3% Upside | Upgrade to Pro+ | |
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.85T | -48.5x | 16.7 | ₩102,400 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.73T | -9,116.8x | -94.5 | ₩26,700 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.58T | 1.99 | ₩77,200 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.5% Upside | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.57T | 52.6x | -4.4 | ₩33,500 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.52T | 0.36 | ₩32,400 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.46T | 50.5x | 0.26 | ₩134,300 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lunit | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩1.41T | -19.5x | 0.51 | ₩48,400 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.8% Upside | Upgrade to Pro+ | |
SD Biosensor | Seoul | Healthcare | Healthcare Equipment & Supplies | ₩1.39T | -13.8x | -0.22 | ₩11,580 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.8% Downside | Upgrade to Pro+ | |
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.26T | -777.4x | 5.6 | ₩25,100 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.19T | -51.7x | 0.37 | ₩39,650 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.18T | 0.07 | ₩164,700 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.2% Upside | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.17T | 28.1x | ₩41,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.13T | 12x | -0.24 | ₩85,500 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.3% Upside | Upgrade to Pro+ | |
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩1.12T | 16.5x | -0.31 | ₩27,550 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.5% Upside | Upgrade to Pro+ | |
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.11T | ₩18,180 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.08T | 2,834.6x | 28.85 | ₩28,100 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.02T | -20.8x | 0.22 | ₩49,150 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Won Tech Co | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩891.67B | 23.7x | 4.08 | ₩9,750 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -29% Downside | Upgrade to Pro+ | |
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩756.44B | 13.1x | 0.92 | ₩17,250 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.5% Upside | Upgrade to Pro+ | |
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩740.11B | 10.2x | 0.49 | ₩113,900 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩726.28B | 13.7x | -0.8 | ₩8,650 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩717.65B | -18.3x | ₩11,940 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩710.37B | -3.6x | 0.02 | ₩5,860 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩665.56B | 9.9x | 0.05 | ₩16,160 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩665.56B | 9.9x | 0.05 | ₩45,500 | 30% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | ₩653.26B | -25x | 0 | ₩7,750 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
L&C Bio | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩649B | 0.03 | ₩26,900 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | ₩635.87B | -45.9x | -0.63 | ₩10,910 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | ₩635.87B | -45.9x | -0.63 | ₩33,100 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viol | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩617.85B | 39.6x | ₩10,280 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |